Advertisement
Sino Biological
Sino Biological

Gene therapy for Duchenne muscular dystrophy

An adeno-associated viral vector has successfully been used to deliver truncated versions of the dystrophin gene in a mouse model for DMD.

By | November 28, 2000

Duchenne muscular dystrophy (DMD) is the most common genetic muscle disorder, affecting 23,000 boys in the US each year. The disease results from a mutation in the gene that encodes dystrophin — the largest gene discovered to date. Adeno-associated viruses have proven the safest and most effective vehicles for delivering therapeutic genes into the muscle tissue but they are too small to carry a dystrophin gene. Now, the development of dystrophin 'mini-genes' might have resolved that problem.

In a study published in the 5 December issue of Proceedings of the National Academy of Sciences, Dr Xiao Xiao and colleagues from the University of Pittsburgh created miniature versions of dystrophin genes that were one-third the normal size. Adeno-associated viral 'packages' carrying truncated dystrophin genes were injected into the calf muscle of mice unable to produce the dystrophin protein. Functional dystrophin protein was expressed in about 90% of the muscle tissue treated. This expression lasted for at least one year.

The authors hope this gene therapy strategy could be used in a larger animal model, and eventually to treat patients. The team will also be collaborating with other researchers to develop better ways of delivering the DMD mini-gene systemically, as opposed to performing localised injections.

Advertisement
Advertisement

Popular Now

  1. When Does a Smart Mouse Become Human?
  2. Most Earth-like Planet Found
  3. The Lies That Scars Tell
    Notebook The Lies That Scars Tell

    Macaque trainers in Bangladesh are often bitten by their monkeys, but rarely infected by a particular simian retrovirus.

  4. AAAAA Is for Arrested Translation
Advertisement
Advertisement
The Scientist